Included In This Lesson
Outline
What is the Generic Name
BELZUTIFAN
What is the Trade Name for BELZUTIFAN
WELIREG
What is the Indication for BELZUTIFAN
- 1 INDICATIONS AND USAGE WELIREG is indicated for treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery. WELIREG is a hypoxia-inducible factor inhibitor indicated for treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery. ( 1 )
View Our Nursing Pharmacology Course
References: https://open.fda.gov/